NexImmune, Inc.
OTC: NEXI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Craig R. Jalbert
- Employees
- 6
- Headquarters
- Gaithersburg, United States
- IPO year
- 2021
- Market cap
- $139.0
- Website
- https://www.neximmune.com
Loading NEXI…
Loading profile data…Frequently asked questions about NEXI
What does NexImmune, Inc. (NEXI) do?
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a vivo directly injectable moda...
Where does NEXI trade?
NexImmune, Inc. (NEXI) trades on the Other OTC.
What sector is NEXI in?
NexImmune, Inc. (NEXI) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of NexImmune, Inc.?
Craig R. Jalbert is the chief executive officer of NexImmune, Inc. (NEXI).
Where is NexImmune, Inc. headquartered?
NexImmune, Inc. is headquartered in United States.
Does NEXI pay a dividend?
NexImmune, Inc. (NEXI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NEXI go public?
NexImmune, Inc. (NEXI) completed its initial public offering in 2021.